Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-29 ±Ý 16:33
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 24°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Cover Story]
°íÇ÷¾Ð °ü¸®ÀÇ ³Á¦ Ç÷¾Ð º¯µ¿¼º
ÀÌ»óµ· ±âÀÚ
2019-07-31 10:57
[Sub Story]
´ëÇѹα¹ °íÇ÷¾ÐÀº 140/90mmHg ÀÌ»óºÎÅÍ
ÀÓ¼¼Çü ±âÀÚ
2019-07-31 10:52
[Sub Story]
¼öÀºÇ÷¾Ð°è ½Ã´ëÀÇ Á¾Âø ÀÌÈÄ ´ë¾ÈÀº?
ÀÓ¼¼Çü ±âÀÚ
2019-07-31 10:49
[Sub Story]
µ¿¹ÝÀÌȯÀ² ³ôÀºµ¥ Ä¡·á´Â ±Û½ê¡¦
ÀÌ»óµ· ±âÀÚ
2019-07-31 10:46
[Sub Story]
ðÈ¡¤ñ¸¡¤å¨ Ç÷¾ÐÁ¶ÀýÀº °è¼ÓµÅ¾ß ÇÑ´Ù
ÀÌ»óµ· ±âÀÚ
2019-07-31 10:42
¶óÀÎ
[Sub Story]
¸ñǥġ ³·ÃßÀÚ Ä¡·á ¾Õ´ç°ÜÁ®
ÀÌ»óµ· ±âÀÚ
2019-07-31 10:40
[Sub Story]
ÁßÁõ ¹× Á¶±âÀû¿ë¿¡ º´¿ë º¹ÇÕÁ¦ Àü¼º±â
ÀÌ»óµ· ±âÀÚ
2019-07-31 10:36
[Sub Story]
¡°¾à ³Ê¹« ¸¹¾Æ Èûµé´Ù¡±
ÀÌ»óµ· ±âÀÚ
2019-07-31 10:32
[Sub Story]
¡°Ç÷°ü¼º Ä¡¸Å ¸·À¸·Á¸é, °íÇ÷¾Ð °ü¸®°¡ ÃÖ¿ì¼±¡±
ÀÌ»óµ· ±âÀÚ
2019-07-31 10:30
[Sub Story]
¡°´ç´¢º´ÀÇ µ¶¸³ÀûÀÎ À§ÇèÀÎÀÚ¡±
ÀÌ»óµ· ±âÀÚ
2019-07-31 10:28
¶óÀÎ
[Sub Story]
Ç÷¾Ð¡¤ÁöÁú µ¿½Ã°ø·«ÇÏ¸é ½ÉÇ÷°ü»ç°Ç¡é
ÀÌ»óµ· ±âÀÚ
2019-07-31 10:21
[Late Breaking Studies]
°í·É 130mmhg ¹Ì¸¸¿¡ ³ú¹éÁúÇãÇ÷¼Õ»ó °³¼±
ÀÌ»óµ· ±âÀÚ
2019-07-31 10:17
[Interview]
¿©¼º °íÇ÷¾Ð, Æó°æ Àü°ú ÈÄ·Î ³ª´¶´Ù
ÀÌ»óµ· ±âÀÚ
2019-07-31 10:04
[Sub Story]
ºñ¸¸¼º °íÇ÷¾Ð¿¡ ¡°RAAS ¾ïÁ¦ Á߿䡱
ÀÌ»óµ· ±âÀÚ
2019-07-31 09:58
[Interview]
¡°Àû±ØÀû Ç÷¾ÐÁ¶Àý, CVD °ü¸® À§ÇÑ ÇʼöÁ¶°Ç¡± CCB + ARB º´¿ë¿ä¹ý ¿ì¼± Àû¿ë¡¦
ÀÓ¼¼Çü ±âÀÚ
2019-07-31 09:54
¶óÀÎ
[Conference Report]
¡®The Lower, The Better¡¯ ½Ã´ëÀÇ ARB ±â¹Ý Àü·«Àº?
ÀÓ¼¼Çü ±âÀÚ
2019-07-31 09:45
[Conference Report]
¼Òµæ¼öÁØ ³·À»¼ö·Ï À¯º´·ü ³ô°í Áö¼ÓÄ¡·áÀ² ³·¾Æ
ÀÓ¼¼Çü ±âÀÚ
2019-07-31 09:35
[Conference Report]
¿Ã¸Þ»ç¸£Åº ±â¹Ý 3Á¦ º¹ÇÕÁ¦, ÀÓ»óÇýÅ᤼øÀÀµµ ¸ðµÎ Àâ´Â´Ù.
ÀÓ¼¼Çü ±âÀÚ
2019-07-31 09:32
[Conference Report]
Ä«³ªºê Æйи®, ó¹æ½ÃÀå ¼¼°è·Î È®´ë
ÀÓ¼¼Çü ±âÀÚ
2019-07-31 09:31
[Conference Report]
ºñ¼öÀºÇ÷¾Ð°è ½Ã´ë, ´ë¾ÈÀ» ³íÇÏ´Ù
ÀÓ¼¼Çü ±âÀÚ
2019-07-31 09:29
-
1
2
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top